Amber Therapeutics: Landmark $100M Series A

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/b1/36/8d/b1368de4-f3ad-0cac-6aa6-e3572beddd43/mza_4184130727494332581.jpg/600x600bb.jpg

Conversations from LSI

LSI

117 episodes

1 week ago

Conversations from LSI brings you the panels, workshops, and key discussions from LSI’s global events—now available on your favorite podcast platforms. Tune in for real insights from the world’s leading medtech and healthtech innovators, investors, and strategics.

Medicine

Health & Fitness

RSS

All content for Conversations from LSI is the property of LSI and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43956871/43956871-1750895889873-443fd0ea935d8.jpg

Amber Therapeutics: Landmark $100M Series A | LSI Europe '24

Conversations from LSI

38 minutes 22 seconds

1 month ago

Amber Therapeutics: Landmark $100M Series A | LSI Europe '24

This keynote took place at LSI Europe ‘24 Emerging Medtech Summit in Sintra, Portugal.

Led by Henry Peck, Aidan Crawley shares the story of Amber Therapeutics massive $100M Series A alongside several VCs who talk about the motivations behind the funding round.

This keynote featured:

Henry Peck — LSI

Aidan Crawley — Amber Therapeutics

Murielle Thinard McLane — Intuitive Ventures

Liliane Chamas — Oxford Science Enterprises

Caroline Gaynor — Lightstone Ventures

Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits

LinkedIn: https://www.linkedin.com/company/life-science-intelligence/

Twitter: https://twitter.com/lsintelligence

Instagram: https://www.instagram.com/lifescienceintelligence/

Facebook: https://www.facebook.com/LifeScienceIntelligence/

Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw